Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medsol RX vs TeleZen MD

Medsol RX
Graded #306

Higher grade

vs+0.6000000000000014
TeleZen MD
Graded #324

Lower grade

The verdict

Medsol RX takes it — 61/100 to 60.4/100, but only just.

Medsol RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medsol RX is a GLP-1 weight-loss telehealth program offering compounded semaglutide (from $209/mo) and tirzepatide, prescribed by board-certified clinicians via OpenLoop and shipped nationwide. TeleZen MD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
64
64
Clinical oversightTeleZen MD +7
79
86
Labs & monitoringEven
53
53
FulfillmentMedsol RX +21
83
62
Contract termsTeleZen MD +6
41
47
Medsol RX · left barTeleZen MD · right bar

The numbers

MetricMedsol RXTeleZen MD
WeighScore61/10060.4/100
GradeCC
Scorecard rank#306#324
Semaglutide$209/mo (compounded)$198/mo (compounded)
Tirzepatide$250/mo (compounded)$298/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
TeleZen MD

Graded #324 · C

Strengths

  • Says it serves all 50 states — among the broadest claimed reach in the compounded segment
  • Markets U.S.-based, FDA-registered pharmacies
  • $100 off your first order with code WELCOME100
  • Fully online U.S. telehealth model with physician evaluation
  • Education-forward, physician-led positioning

Where it loses points

  • Partner pharmacy not named
  • Legal entity name and state of incorporation not disclosed
  • Brand-name medications not addressed on the homepage
  • LegitScript certification not confirmed
  • All-50-states claim is the provider's own, not independently verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard